drugset / Trial / NCT03213769

Clinical Evaluation of Topical Coenzyme Q10 in Management of Oral Aphthous Ulcer

NCT03213769

Unknown 52 enrolled Cairo University
RandomizedParallel-groupDouble-blindTreatment

Summary

Recurrent oral aphthous ulcer is the most common oral lesion in occurrence and one of cause is oxidative stress so investigators need to use antioxidant drugs like topical coenzyme Q10 gel to treat the lesion and more safe for the participants.

Timeline

Start
2017-07
Primary completion
2018-07
Completion
2018-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Coenzyme Q10 Other / unclassified Topical

Indications